Log in
Enquire now
Tridek-One

Tridek-One

Tridek-One develops first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases

OverviewStructured DataIssuesContributors
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Tridek-One

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.